Eur Rev Med Pharmacol Sci 2022; 26 (18): 6404-6404

DOI: 10.26355/eurrev_202209_29738

C.-C. Hu, Y.-W. Liang, J.-L. Hu, L.-F. Liu, J.-W. Liang, R. Wang

Department of Oncology, the Affiliate Hospital of Chengde Medical University, Chengde, China

The article “LncRNA RUSC1-AS1 promotes the proliferation of breast cancer cells by epigenetic silence of KLF2 and CDKN1A, by C.-C. Hu, Y.-W. Liang, J.-L. Hu, L.-F. Liu, J.-W. Liang, R. Wang, published in Eur Rev Med Pharmacol Sci 2019; 23 (15): 6602-6611–DOI: 10.26355/eurrev_201908_18548–PMID: 31378902” has been retracted by the authors.

After publication, the article was questioned on PubPeer. Concerns were raised about Figure 2, Table I, and the reliability of the published results. The same authors stated that they want to rearrange the manuscript and provide readers with a more precise model.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License

C.-C. Hu, Y.-W. Liang, J.-L. Hu, L.-F. Liu, J.-W. Liang, R. Wang
Retraction Note: LncRNA RUSC1-AS1 promotes the proliferation of breast cancer cells by epigenetic silence of KLF2 and CDKN1A

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 18
Pages: 6404-6404
DOI: 10.26355/eurrev_202209_29738

Tag: Retraction notice